Nymox Director Robinson adds more shares in the market

Posted on by

Nymox Pharmaceutical Corporation {NASDAQ: NYMX} Director James G Robinson purchased 20,000 shares of the company’s stock in a transaction dated Thursday, July 7th.

The consideration was $65,600.

 

Nymox Pharmaceutical Corporation {NASDAQ: NYMX} Director James  Robinson purchased 20,000 shares of the company’s stock in a transaction dated Thursday, July 7th.

 

The shares were bought at an average price of $3.28 per share, for a total consideration of $65,600.00.

 

Following the completion of the transaction, Robinson now owns 2,850,050 shares in the company